Short Summary
The plaintiffs filed an application before the Delhi High Court challenging an anti-suit injunction issued by the Wuhan Intermediate People's Court, which sought to restrain them from prosecuting their SEP royalty rate suit in India. The court found a clear case for granting ad interim relief.
Detailed Summary
In the high-stakes world of standard essential patents, lawsuits are not just about technology, they are about leverage. When a foreign court issues an order designed to stop a company from fighting in another country, the question becomes: can local courts push back? The clash between Interdigital Technology Corporation and Xiaomi Corporation before the Delhi High Court offers a fascinating answer, and a critical lesson for any founder whose business depends on intellectual property.
Interdigital Technology Corporation, a holder of Standard Essential Patents (SEPs), found itself in a royalty rate dispute with Xiaomi Corporation, the global smartphone giant. SEPs are patents that cover technology considered essential to industry standards, meaning every player in the market must use them. Disputes over how much should be paid in royalties for these patents are common, and they often spill across borders. Interdigital had initiated a SEP royalty rate suit in India, seeking to determine fair, reasonable, and non-discriminatory (FRAND) terms for Xiaomi's use of its patented technology. Just as this Indian litigation was progressing, the Wuhan Intermediate People's Court in China issued an anti-suit injunction, an order designed to restrain Interdigital from prosecuting its SEP royalty rate suit in India. Faced with being silenced in its own chosen forum, Interdigital approached the Delhi High Court to challenge this foreign restraint.
The core legal friction was jurisdictional and strategic. Interdigital argued that the Wuhan court's anti-suit injunction was an overreach, an attempt by a foreign court to control litigation that was properly before Indian courts. By seeking to halt the Indian SEP royalty proceedings, the Chinese order interfered with the sovereignty of Indian judicial processes. On the other side, Xiaomi and the respondents leaned on the authority of the Wuhan court's order, effectively arguing that Interdigital should be bound by the foreign injunction. The legal tension centered on a fundamental question: should a party be allowed to use a foreign court order as a weapon to block legitimate litigation in another jurisdiction? The Delhi High Court had to weigh whether the anti-suit injunction itself could be treated as an actionable wrong that warranted Indian judicial intervention.
The Delhi High Court found a clear case for granting ad interim relief in favor of Interdigital. By stepping in to restrain the effect of the Wuhan court's anti-suit injunction, the court signaled that foreign judicial orders cannot be allowed to paralyze litigation that is properly before Indian courts. The interim order preserved Interdigital's right to continue pursuing its SEP royalty rate suit in India, ensuring that the Indian judicial process would not be hijacked by extraterritorial maneuvering. The court's reasoning underscored a powerful principle: Indian courts retain the authority to protect the integrity of proceedings within their jurisdiction, even when faced with conflicting orders from foreign tribunals.
For founders, IP professionals, and startup leaders operating in global technology markets, this case is a wake-up call. If your business relies on standard essential patents or any cross-border IP licensing, you must be prepared for the reality that litigation can become a multi-front war. A foreign court order designed to block your lawsuit is not the end of the road, it can be challenged in Indian courts. The key lesson is to act quickly: the moment a foreign anti-suit injunction threatens your ability to litigate in India, seek immediate relief from the relevant High Court. Do not assume that a foreign ruling is final or enforceable in India. Build your IP strategy with the assumption that jurisdictional battles will arise, and ensure your legal counsel is ready to defend your right to be heard in the forum of your choice.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court. Understanding the court's reasoning in Interdigital Technology Corporation & Ors. vs Xiaomi Corporation & Ors. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Natalja EikjevsJoint Controller Of Patents And Designs
Natalja Eikje filed an appeal challenging the order passed by the Controller of Patents which refused the entire set of 16 claims in Indian Patent Application No. 7173/DELNP/2014. The appellant argued that since no objection was raised against specific claims (claims 7-16), refusing the entire application violated the Principles of Natural Justice.
Gilead Sciences Inc.vsUnion of India
Gilead Sciences Inc. challenged a hearing notice and subsequent opposition board recommendation related to Indian Patent No.319927, arguing that the process violated The Patents Act, 1970 by not allowing them to present evidence. The Court quashed the impugned notices and recommendations.
S.GiridharanvsS.Sudhakar
The Madras High Court dismissed Civil Suit No. 193 of 2025 following a comprehensive settlement reached between the plaintiff, S.Giridharan, and several defendants. The suit, which sought declarations regarding ownership of the registered trademark UDHAIYAM and related injunctions, was resolved through a joint memorandum of settlement dated August 8, 2025. This agreement allowed the plaintiff to withdraw claims against certain parties while acknowledging existing titles held by others, leading to the final dismissal of the suit.
Boehringer Ingelheim International GmbHvsEris Lifesciences Limited
The plaintiffs, Boehringer Ingelheim International GmbH (through its Power of Attorney Holder), filed an application seeking interim relief against Eris Lifesciences Limited for infringing Indian Patent No. 268846. The patent covers pharmaceutical products like Empagliflozin and related formulations. The court found that the plaintiffs had established a prima facie case, leading to the grant of an injunction.
M/S. Tvs Motor Company LimitedvsThe Assistant Controller of Patents & Designs, Patent Office
TVS Motor Company Limited appealed an order by the Assistant Controller of Patents rejecting its application for "Vehicle Frame Assembly" on grounds including lack of inventive step, exclusion under Section 3(f), and formal requirements. The appellant argued that the rejection failed to follow a proper five-step analysis when assessing obviousness against cited prior art. The High Court set aside the impugned order and remanded the application for reconsideration.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.